 David Irwin
Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemoglobins | 10 | 2021 | 326 | 3.630 |
Why?
| | Anemia, Sickle Cell | 9 | 2023 | 230 | 3.540 |
Why?
| | Hypoxia | 10 | 2022 | 963 | 1.320 |
Why?
| | Altitude | 4 | 2022 | 422 | 1.300 |
Why?
| | Altitude Sickness | 3 | 2016 | 163 | 1.150 |
Why?
| | Hypertension, Pulmonary | 7 | 2022 | 1794 | 1.140 |
Why?
| | Hemopexin | 3 | 2021 | 13 | 1.030 |
Why?
| | Pulmonary Edema | 2 | 2019 | 125 | 1.000 |
Why?
| | beta-Thalassemia | 1 | 2023 | 23 | 0.930 |
Why?
| | Pulmonary Ventilation | 1 | 2022 | 71 | 0.850 |
Why?
| | Haptoglobins | 3 | 2018 | 49 | 0.810 |
Why?
| | Vascular Remodeling | 3 | 2022 | 152 | 0.790 |
Why?
| | Capillary Permeability | 4 | 2016 | 140 | 0.770 |
Why?
| | Beta vulgaris | 1 | 2020 | 4 | 0.770 |
Why?
| | Rats | 15 | 2022 | 5392 | 0.750 |
Why?
| | Pulmonary Artery | 6 | 2022 | 1063 | 0.740 |
Why?
| | Emulsions | 1 | 2019 | 45 | 0.720 |
Why?
| | Oxygen | 4 | 2022 | 854 | 0.710 |
Why?
| | Endothelium, Vascular | 3 | 2018 | 907 | 0.700 |
Why?
| | Vasodilator Agents | 2 | 2013 | 328 | 0.690 |
Why?
| | Blood Substitutes | 2 | 2009 | 28 | 0.670 |
Why?
| | Reactive Oxygen Species | 2 | 2013 | 576 | 0.660 |
Why?
| | Rats, Sprague-Dawley | 10 | 2019 | 2478 | 0.650 |
Why?
| | Fluorocarbons | 1 | 2019 | 105 | 0.630 |
Why?
| | Lung | 4 | 2018 | 3664 | 0.630 |
Why?
| | Animals | 30 | 2023 | 33381 | 0.620 |
Why?
| | Microvessels | 1 | 2018 | 77 | 0.600 |
Why?
| | Physical Exertion | 1 | 2018 | 222 | 0.600 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 30 | 0.590 |
Why?
| | Carbonic Anhydrase Inhibitors | 1 | 2016 | 18 | 0.590 |
Why?
| | Cerebral Veins | 1 | 2016 | 16 | 0.580 |
Why?
| | Drug Delivery Systems | 1 | 2019 | 306 | 0.580 |
Why?
| | Angiogenesis Inducing Agents | 1 | 2016 | 24 | 0.580 |
Why?
| | Brain Edema | 1 | 2016 | 61 | 0.570 |
Why?
| | Water | 1 | 2019 | 425 | 0.570 |
Why?
| | Macrophages | 2 | 2023 | 1324 | 0.570 |
Why?
| | Cerebral Arteries | 1 | 2016 | 56 | 0.570 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2013 | 83 | 0.540 |
Why?
| | Atrial Natriuretic Factor | 2 | 2005 | 59 | 0.510 |
Why?
| | Muscle Contraction | 1 | 2018 | 413 | 0.510 |
Why?
| | Angiogenesis Inhibitors | 1 | 2016 | 219 | 0.510 |
Why?
| | Hemolysis | 4 | 2021 | 174 | 0.510 |
Why?
| | Endothelial Cells | 2 | 2013 | 732 | 0.490 |
Why?
| | Transcriptional Activation | 2 | 2013 | 348 | 0.470 |
Why?
| | Vascular Diseases | 2 | 2015 | 241 | 0.450 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2013 | 95 | 0.450 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2014 | 246 | 0.430 |
Why?
| | Oxygen Consumption | 2 | 2020 | 586 | 0.420 |
Why?
| | Mice | 13 | 2023 | 15520 | 0.370 |
Why?
| | Glutaral | 1 | 2009 | 15 | 0.350 |
Why?
| | Lung Diseases | 2 | 2015 | 718 | 0.350 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2009 | 36 | 0.350 |
Why?
| | Phenylpropionates | 2 | 2019 | 17 | 0.340 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 2009 | 86 | 0.340 |
Why?
| | Sulfones | 1 | 2009 | 98 | 0.330 |
Why?
| | Pyridazines | 2 | 2019 | 50 | 0.330 |
Why?
| | Muscle, Skeletal | 1 | 2018 | 1515 | 0.330 |
Why?
| | Disease Progression | 3 | 2023 | 2490 | 0.320 |
Why?
| | Inflammation | 3 | 2023 | 2566 | 0.320 |
Why?
| | Vascular Resistance | 3 | 2016 | 356 | 0.320 |
Why?
| | Endothelins | 2 | 2018 | 62 | 0.320 |
Why?
| | Polymers | 2 | 2009 | 482 | 0.300 |
Why?
| | Piperazines | 1 | 2009 | 316 | 0.290 |
Why?
| | Lipid Peroxidation | 3 | 2018 | 156 | 0.290 |
Why?
| | Respiration | 2 | 2022 | 183 | 0.280 |
Why?
| | Nitric Oxide | 3 | 2018 | 892 | 0.280 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2009 | 527 | 0.280 |
Why?
| | Disease Models, Animal | 7 | 2022 | 3730 | 0.280 |
Why?
| | Cell Nucleus | 1 | 2009 | 580 | 0.270 |
Why?
| | Male | 16 | 2021 | 57801 | 0.270 |
Why?
| | Cardiac Output | 3 | 2012 | 147 | 0.260 |
Why?
| | Capillary Leak Syndrome | 1 | 2005 | 13 | 0.260 |
Why?
| | Muscle, Smooth, Vascular | 4 | 2017 | 454 | 0.260 |
Why?
| | Neprilysin | 1 | 2005 | 48 | 0.250 |
Why?
| | Heme | 2 | 2021 | 54 | 0.240 |
Why?
| | Blood Pressure | 4 | 2018 | 1664 | 0.230 |
Why?
| | Oxidation-Reduction | 3 | 2018 | 940 | 0.230 |
Why?
| | Endothelin-1 | 1 | 2005 | 168 | 0.230 |
Why?
| | Intercellular Adhesion Molecule-1 | 2 | 2015 | 175 | 0.220 |
Why?
| | Mice, Inbred C57BL | 4 | 2018 | 4908 | 0.220 |
Why?
| | Pulmonary Circulation | 2 | 2019 | 424 | 0.220 |
Why?
| | Oxyhemoglobins | 1 | 2021 | 22 | 0.210 |
Why?
| | Extracellular Vesicles | 1 | 2023 | 76 | 0.210 |
Why?
| | Magnetics | 1 | 2021 | 38 | 0.200 |
Why?
| | Scleroderma, Systemic | 1 | 2022 | 94 | 0.200 |
Why?
| | Humans | 20 | 2023 | 118974 | 0.200 |
Why?
| | Alternative Splicing | 1 | 2022 | 193 | 0.190 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 509 | 0.190 |
Why?
| | Muscle Proteins | 1 | 2022 | 219 | 0.190 |
Why?
| | Metabolic Diseases | 1 | 2021 | 103 | 0.190 |
Why?
| | Monocytes | 1 | 2023 | 513 | 0.190 |
Why?
| | CD40 Antigens | 1 | 2021 | 80 | 0.190 |
Why?
| | Nitrates | 1 | 2020 | 78 | 0.190 |
Why?
| | RNA, Long Noncoding | 1 | 2022 | 161 | 0.180 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2021 | 200 | 0.180 |
Why?
| | Histone Deacetylases | 2 | 2012 | 198 | 0.180 |
Why?
| | Up-Regulation | 2 | 2013 | 872 | 0.180 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2019 | 180 | 0.170 |
Why?
| | Gadolinium | 1 | 2019 | 79 | 0.170 |
Why?
| | Enoyl-CoA Hydratase | 1 | 2018 | 9 | 0.170 |
Why?
| | Lipids | 2 | 2023 | 607 | 0.170 |
Why?
| | Exercise Tolerance | 1 | 2020 | 233 | 0.170 |
Why?
| | Double-Blind Method | 2 | 2020 | 1687 | 0.170 |
Why?
| | Antibodies | 1 | 2021 | 392 | 0.170 |
Why?
| | Metabolome | 1 | 2021 | 296 | 0.170 |
Why?
| | Cell Line | 2 | 2015 | 2707 | 0.160 |
Why?
| | Blood Gas Analysis | 2 | 2008 | 69 | 0.160 |
Why?
| | Liver Diseases | 1 | 2021 | 282 | 0.160 |
Why?
| | Carrier Proteins | 1 | 2022 | 726 | 0.160 |
Why?
| | Aminophylline | 1 | 2017 | 5 | 0.160 |
Why?
| | Lipoproteins | 1 | 2018 | 162 | 0.150 |
Why?
| | Proteomics | 1 | 2023 | 876 | 0.150 |
Why?
| | Antioxidants | 2 | 2013 | 564 | 0.150 |
Why?
| | Acclimatization | 1 | 2018 | 135 | 0.150 |
Why?
| | Anemia, Hemolytic | 1 | 2017 | 19 | 0.150 |
Why?
| | Deferoxamine | 1 | 2016 | 17 | 0.150 |
Why?
| | Cell Proliferation | 2 | 2017 | 2275 | 0.150 |
Why?
| | Acetazolamide | 1 | 2016 | 28 | 0.150 |
Why?
| | Cells, Cultured | 6 | 2014 | 4077 | 0.150 |
Why?
| | Mice, Knockout | 3 | 2022 | 2680 | 0.150 |
Why?
| | Dietary Supplements | 1 | 2020 | 467 | 0.140 |
Why?
| | Niacinamide | 1 | 2016 | 70 | 0.140 |
Why?
| | Myocytes, Cardiac | 3 | 2022 | 472 | 0.140 |
Why?
| | Antihypertensive Agents | 1 | 2019 | 437 | 0.140 |
Why?
| | Oxidative Stress | 2 | 2012 | 1178 | 0.140 |
Why?
| | NF-kappa B | 2 | 2013 | 670 | 0.140 |
Why?
| | Oligonucleotides | 1 | 2016 | 140 | 0.140 |
Why?
| | Methemoglobin | 2 | 2021 | 22 | 0.130 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2018 | 344 | 0.130 |
Why?
| | Signal Transduction | 5 | 2017 | 4709 | 0.130 |
Why?
| | Vasoconstriction | 1 | 2016 | 213 | 0.130 |
Why?
| | Indoles | 1 | 2016 | 316 | 0.120 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2015 | 146 | 0.120 |
Why?
| | Chloride Channels | 1 | 2014 | 35 | 0.120 |
Why?
| | Cattle | 2 | 2008 | 978 | 0.120 |
Why?
| | Genomics | 1 | 2018 | 706 | 0.120 |
Why?
| | RNA, Small Interfering | 3 | 2012 | 564 | 0.120 |
Why?
| | Catalase | 1 | 2013 | 123 | 0.120 |
Why?
| | Cell Membrane Permeability | 1 | 2013 | 88 | 0.120 |
Why?
| | Histone Deacetylase Inhibitors | 2 | 2012 | 200 | 0.110 |
Why?
| | Permeability | 1 | 2013 | 156 | 0.110 |
Why?
| | Iron | 1 | 2015 | 248 | 0.110 |
Why?
| | Interleukin-6 | 1 | 2017 | 688 | 0.110 |
Why?
| | Ventricular Remodeling | 2 | 2012 | 229 | 0.110 |
Why?
| | Cyclic N-Oxides | 1 | 2012 | 31 | 0.110 |
Why?
| | Infusion Pumps | 1 | 2012 | 32 | 0.110 |
Why?
| | Spin Labels | 1 | 2012 | 50 | 0.110 |
Why?
| | Heart Failure | 2 | 2022 | 1969 | 0.110 |
Why?
| | Mitochondrial Proteins | 1 | 2014 | 226 | 0.100 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 219 | 0.100 |
Why?
| | Macrophages, Alveolar | 1 | 2015 | 359 | 0.100 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 339 | 0.100 |
Why?
| | Cardiovascular Diseases | 2 | 2021 | 1798 | 0.100 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2012 | 290 | 0.100 |
Why?
| | Cerebellum | 1 | 2013 | 203 | 0.100 |
Why?
| | Toll-Like Receptor 4 | 1 | 2013 | 330 | 0.100 |
Why?
| | Hydrogen Peroxide | 1 | 2012 | 305 | 0.090 |
Why?
| | Microcirculation | 2 | 2014 | 155 | 0.090 |
Why?
| | Blotting, Western | 1 | 2012 | 1194 | 0.090 |
Why?
| | Sildenafil Citrate | 1 | 2009 | 57 | 0.090 |
Why?
| | Pneumonia | 1 | 2015 | 592 | 0.090 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2009 | 113 | 0.080 |
Why?
| | Female | 7 | 2022 | 61565 | 0.080 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2008 | 48 | 0.080 |
Why?
| | Hypoxia, Brain | 1 | 2008 | 8 | 0.080 |
Why?
| | Purines | 1 | 2009 | 161 | 0.080 |
Why?
| | Hemodynamics | 1 | 2012 | 1004 | 0.080 |
Why?
| | Nitric Oxide Synthase | 1 | 2008 | 225 | 0.080 |
Why?
| | Norepinephrine | 1 | 2008 | 212 | 0.080 |
Why?
| | Dogs | 1 | 2008 | 371 | 0.070 |
Why?
| | Epinephrine | 1 | 2008 | 167 | 0.070 |
Why?
| | Exercise | 1 | 2017 | 1657 | 0.070 |
Why?
| | Protein Isoforms | 2 | 2022 | 345 | 0.070 |
Why?
| | RNA, Messenger | 1 | 2013 | 2657 | 0.070 |
Why?
| | Myocardium | 1 | 2011 | 970 | 0.070 |
Why?
| | Treatment Outcome | 1 | 2019 | 9342 | 0.070 |
Why?
| | Stroke Volume | 1 | 2008 | 513 | 0.070 |
Why?
| | Stress Fibers | 1 | 2004 | 18 | 0.060 |
Why?
| | Kidney | 1 | 2012 | 1353 | 0.060 |
Why?
| | Enzyme Inhibitors | 1 | 2008 | 827 | 0.060 |
Why?
| | Heart Rate | 1 | 2008 | 729 | 0.060 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 285 | 0.060 |
Why?
| | Actins | 1 | 2004 | 404 | 0.050 |
Why?
| | Catecholamines | 1 | 2022 | 100 | 0.050 |
Why?
| | Hypertension | 1 | 2011 | 1203 | 0.050 |
Why?
| | RNA Splicing Factors | 1 | 2022 | 50 | 0.050 |
Why?
| | Thrombin | 1 | 2023 | 143 | 0.050 |
Why?
| | Lung Neoplasms | 1 | 2014 | 2220 | 0.050 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2022 | 310 | 0.050 |
Why?
| | Etanercept | 1 | 2021 | 51 | 0.050 |
Why?
| | Lipopolysaccharides | 1 | 2004 | 870 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2018 | 3171 | 0.050 |
Why?
| | Arrhythmias, Cardiac | 1 | 2022 | 277 | 0.050 |
Why?
| | Ligands | 1 | 2021 | 567 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2022 | 404 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2004 | 1171 | 0.040 |
Why?
| | Fatty Acids | 1 | 2022 | 407 | 0.040 |
Why?
| | Tissue Donors | 1 | 2021 | 336 | 0.040 |
Why?
| | Guinea Pigs | 1 | 2018 | 151 | 0.040 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2018 | 111 | 0.040 |
Why?
| | Heart | 1 | 2022 | 631 | 0.040 |
Why?
| | Linkage Disequilibrium | 1 | 2018 | 273 | 0.040 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2021 | 228 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2021 | 502 | 0.040 |
Why?
| | Cytoskeleton | 1 | 2018 | 181 | 0.040 |
Why?
| | Genetics, Population | 1 | 2018 | 207 | 0.040 |
Why?
| | Gene Regulatory Networks | 1 | 2018 | 239 | 0.040 |
Why?
| | Proteins | 1 | 2023 | 938 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 409 | 0.040 |
Why?
| | Heart Ventricles | 2 | 2012 | 727 | 0.030 |
Why?
| | Mice, Inbred Strains | 2 | 2014 | 405 | 0.030 |
Why?
| | Adenosine | 1 | 2017 | 211 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2021 | 2025 | 0.030 |
Why?
| | Sarcoma, Experimental | 1 | 2014 | 5 | 0.030 |
Why?
| | Rats, Nude | 1 | 2014 | 27 | 0.030 |
Why?
| | Intravital Microscopy | 1 | 2014 | 25 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2017 | 965 | 0.030 |
Why?
| | Heterografts | 1 | 2014 | 130 | 0.030 |
Why?
| | Coronary Vessels | 1 | 2016 | 233 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1715 | 0.030 |
Why?
| | Adult | 3 | 2023 | 31512 | 0.030 |
Why?
| | Transcription Factor RelA | 1 | 2014 | 82 | 0.030 |
Why?
| | Swine | 1 | 2016 | 730 | 0.030 |
Why?
| | Blood Flow Velocity | 1 | 2014 | 327 | 0.030 |
Why?
| | Genotype | 1 | 2018 | 1882 | 0.030 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2014 | 193 | 0.030 |
Why?
| | Chemistry, Physical | 1 | 2012 | 40 | 0.030 |
Why?
| | Cytokines | 1 | 2021 | 1900 | 0.030 |
Why?
| | Mitochondria | 1 | 2018 | 786 | 0.030 |
Why?
| | Neovascularization, Pathologic | 1 | 2014 | 287 | 0.030 |
Why?
| | Fructans | 1 | 1992 | 1 | 0.030 |
Why?
| | Genes, Immunoglobulin | 1 | 1992 | 26 | 0.030 |
Why?
| | Immunoglobulin Light Chains | 1 | 1992 | 35 | 0.030 |
Why?
| | Young Adult | 2 | 2018 | 10793 | 0.030 |
Why?
| | Immunoglobulin Variable Region | 1 | 1992 | 71 | 0.030 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 1992 | 72 | 0.030 |
Why?
| | MicroRNAs | 1 | 2018 | 637 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1597 | 0.030 |
Why?
| | Histone Deacetylase 6 | 1 | 2011 | 19 | 0.030 |
Why?
| | Benzamides | 1 | 2012 | 176 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2018 | 2062 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 3003 | 0.020 |
Why?
| | Adenoviridae | 1 | 2011 | 191 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 2012 | 418 | 0.020 |
Why?
| | RNA Interference | 1 | 2011 | 460 | 0.020 |
Why?
| | Pyrimidines | 1 | 2012 | 382 | 0.020 |
Why?
| | Pyridines | 1 | 2012 | 440 | 0.020 |
Why?
| | Cohort Studies | 1 | 2018 | 5116 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1012 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2014 | 2851 | 0.020 |
Why?
| | Middle Aged | 2 | 2018 | 27617 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 1992 | 1284 | 0.020 |
Why?
| | Child | 1 | 2023 | 19129 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 2014 | 1965 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 18480 | 0.010 |
Why?
| | Antibody Diversity | 1 | 1992 | 17 | 0.010 |
Why?
| | Immunoglobulin Isotypes | 1 | 1992 | 32 | 0.010 |
Why?
| | Antibody Specificity | 1 | 1992 | 184 | 0.010 |
Why?
|
|
Irwin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|